THE PRIVY POST

The text-only internet newspaper.

Volume 2 • Issue No. 114 • Updated Friday, April 24, 2026 at 04:22 PM UTC

Justice Department Drops Criminal Probe of Fed Chair Powell, Clearing Path for Successor

The Justice Department has ended its probe into Federal Reserve chair Jerome Powell, clearing a major roadblock to the confirmation of his successor, Kevin Warsh.

Sources: AP News


Iran's Top Diplomat to Travel to Pakistan for Talks on Ceasefire with US

Iran’s top diplomat is set to travel to Pakistan, raising hopes for renewed talks to end the war with the US.

Sources: AP News


Trump Reclassifies Medical Marijuana as Less Dangerous Drug in Historic Shift

Trump reclassifies state-licensed medical marijuana as a less-dangerous drug in a historic shift.

Sources: AP News


Israel and Lebanon Agree to Extend Ceasefire by Three Weeks, Trump Says

Israel and Lebanon agree to extend ceasefire by three weeks, Trump says.

Sources: AP News


US Soldier Charged with Using Classified Intel to Win $400K Bet on Maduro Raid

A US soldier is charged with using classified intelligence to win $400,000 on a Polymarket bet about the Maduro raid.

Sources: AP News


Meta Slashes 8,000 Jobs as Microsoft Offers Buyouts Amid Tech Layoffs

Meta slashes 8,000 jobs, or 10% of its workforce, as Microsoft offers buyouts.

Sources: AP News


Wildfire Destroys Nearly 90 Homes in Georgia, Threatens More Evacuations

A wildfire that has destroyed nearly 90 homes in Georgia threatens more evacuations.

Sources: AP News


Trump Unveils Deal with Regeneron to Lower Drug Prices as Part of Most-Favored-Nation Initiative

Trump unveils a deal with Regeneron to lower drug prices as part of his most-favored-nation initiative.

Sources: AP News


NFL Draft: QB Fernando Mendoza Goes No. 1, Rams Draft Ty Simpson in First Round

The 2026 NFL draft first round highlights: Fernando Mendoza goes No. 1, Rams draft Ty Simpson.

Sources: AP News


FDA Plans Ultra-Fast Review of Three Psychedelic Drugs Following Trump Directive

The FDA plans an ultra-fast review of three psychedelic drugs following a Trump directive.

Sources: AP News